Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

1.6K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
1.6K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

559
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
559
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

680
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
680
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

943
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
943
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

752
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
752
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

384
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
384

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Effectiveness of Imipenem/Relebactam in Patients with Antimicrobial-Resistant Hospital-Acquired Infections: Findings from Systematic Literature Reviews.

Antibiotics (Basel, Switzerland)·2026
Same author

Ceftolozane/Tazobactam for Complex and Resistant Infections: Systematic Reviews of Comparative Efficacy Studies.

Antibiotics (Basel, Switzerland)·2026
Same author

Potentially modifiable ventilatory factors contributing to outcome in patients with pulmonary and extrapulmonary ARDS - An individual patient data analysis.

Journal of clinical anesthesia·2026
Same author

The double threat: bacterial and fungal co-/superinfection in viral pneumonia.

Expert review of respiratory medicine·2026
Same author

Ventilator-associated pneumonia and prior antibiotic exposure in intubated patients due to depressed consciousness.

Medicina intensiva·2026
Same author

Severe community-acquired pneumonia: an integral approach.

Journal of intensive care·2026

Related Experiment Video

Updated: Dec 30, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.3K

Ventilator-associated tracheobronchitis: an update.

Jorge Ibrain Figueira Salluh1,2, Vicente Cés de Souza-Dantas3, Ignacio Martin-Loeches4,5

  • 1Instituto D'Or de Pesquisa e Ensino - Rio de Janeiro (RJ), Brasil.

Revista Brasileira De Terapia Intensiva
|January 23, 2020
PubMed
Summary

Ventilator-associated tracheobronchitis, though previously overlooked, significantly increases costs and ventilation duration. Recognizing this condition is crucial for managing patient care and infection surveillance.

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.3K

Related Experiment Videos

Last Updated: Dec 30, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.3K
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.3K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Ventilator-associated lower respiratory tract infection is a common complication in mechanically ventilated patients.
  • Ventilator-associated tracheobronchitis was historically considered benign and not requiring antibiotic treatment.
  • Recent research suggests tracheobronchitis may precede ventilator-associated pneumonia.

Purpose of the Study:

  • To evaluate the clinical significance and impact of ventilator-associated tracheobronchitis.
  • To assess the association of ventilator-associated tracheobronchitis with patient outcomes and healthcare resource utilization.
  • To highlight the importance of including ventilator-associated tracheobronchitis in clinical management and surveillance.

Main Methods:

  • Literature review and analysis of existing studies on ventilator-associated tracheobronchitis.
  • Examination of epidemiological data and clinical management strategies.
  • Assessment of the impact on mortality, length of stay, antibiotic use, and mechanical ventilation duration.

Main Results:

  • Ventilator-associated tracheobronchitis has a minimal impact on overall mortality.
  • Significant associations found with increased patient costs, prolonged hospital stays, and extended mechanical ventilation.
  • Increased antibiotic use is also linked to ventilator-associated tracheobronchitis.

Conclusions:

  • Ventilator-associated tracheobronchitis, despite low mortality impact, has significant economic and clinical consequences.
  • Management and surveillance strategies should incorporate this condition.
  • Further research is needed to clarify optimal treatment modalities.